Global
CN
EN
HOME
ABOUT US
About Laekna
Core Management Team
Board of Directors
Milestones
Scientific Advisory Board
Core Investors
Honors & Awards
R&D
R&D
Therapeutic Areas
Candidates
Pipeline
Clinical Trials
PARTNERSHIPS
Strategic Partners
Business Development
Holistic Approach
BD Contact
INVESTORS
Corporate Governance
Financial Results
Announcements and Circulars
IR Calendar
Listing Documents
NEWS
Press Releases
Media Coverage
CAREERS
Global Team
Career Development
Jobs
My Laekna
CONTACT US
Contact Us
Leave Message
RSS Feeds
INVESTOR RELATIONS
CURE FOR A BETTER FUTURE
Scroll down to see more
Announcements and Circulars
2024
2023
May 07, 2024
[Monthly Returns]
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2024
More
April 26, 2024
[Environmental, Social and Governance Information/Report]
- 2023 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT
More
April 15, 2024
[VOLUNTARY ANNOUNCEMENT]
- INVESTIGATIONAL NEW DRUG APPROVAL FOR LAE102 FOR THE TREATMENT OF OBESITY WAS OBTAINED FROM THE U.S. FOOD AND DRUG ADMINISTRATION
More
April 03, 2024
[Monthly Returns] -
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024
More
March 26, 2024
Announcements and Notices -
[Final Results] ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2023
More
March 11, 2024
[VOLUNTARY ANNOUNCEMENT] -
SUBMISSION OF INVESTIGATIONAL NEW DRUG APPLICATION FOR LAE102 FOR THE TREATMENT OF OBESITY TO THE U.S. FOOD AND DRUG ADMINISTRATION
More
<
1
3
4
5
6
7
8
>
RSS Feeds
If you want to know more about Laekna, please fill in the form below and sign up for emails:
Name
*
Email
*
Company
Occupation
News
Positions
Follow us on Linkedin
HOME
ABOUT US
R&D
PARTNERSHIPS
INVESTORS
NEWS
CAREERS
CONTACT US
PRIVACY POLICY
占位
Global
—English
|
中国
—简体中文